Jobs
Benefits & Perks
•Healthcare
•401(k)
•Equity
•Parental Leave
•Learning Budget
•Gym
•Healthcare
•401k
•Equity
•Parental Leave
•Learning
•Gym
Required Skills
Market Access Strategy
Launch Leadership
Medicare Reimbursement
Alliance Management
Executive Communication
KPI Definition
Business Review Leadership
About This Role
We are seeking a highly seasoned market access leader to shape U.S. market access strategy for Biogen’s Alzheimer’s portfolio. This senior‑level role carries enterprise‑wide visibility, serving as a key advisor to Biogen’s executive leadership, a strategic partner to Investor Relations, and a critical interface with Biogen’s alliance partners.
As a strategic integrator across Biogen’s Market Access & Reimbursement (MA&R) organization, Alzheimer’s commercial teams, and alliance counterparts, the Senior Director will influence asset‑level strategy, communicate performance to the highest levels of the company – including the CEO, executive leadership, and Board of Directors – and shape business‑critical decisions on access, reimbursement, and patient adoption.
What You’ll Do
- Shape the long‑range market access vision for Biogen's Alzheimer's drug, shaping payer, provider, and site‑of‑care strategies across Medicare (Part B & D), Commercial, and Medicaid channels.
- Establish deep, trust‑based relationships with our external partner's market access executives, serving as Biogen’s senior-most MA&R voice within the alliance.
- Influence strategic choices – including payer strategy, reimbursement initiatives, KPI definitions, SubQ launch positioning, and cross‑company operational alignment.
- Partner directly with Biogen senior leadership, including preparation and briefing for ELT decision forums, portfolio updates, and business reviews.
- Lead development of market access content for Investor Relations, including Q&A preparation, earnings support, external messaging alignment, and scenario analyses.
- Support Board of Directors preparation, shaping clear and compelling narratives around Alzheimer’s access, payer trends, reimbursement challenges/opportunities, and alliance performance.
- Manage governance touchpoints, ensuring Biogen’s perspectives, priorities, and insights shape alliance decisions at senior‑leadership tables.
- Shape the Alzheimer’s access KPI and performance framework, including definition of metrics, dashboard design, insights generation, and monthly/quarterly business reviews with Biogen and Eisai leadership.
- Translate complex access dynamics into executive‑ready storytelling, ensuring clarity across internal stakeholders.
- Guide overall cross‑functional strategic alignment, translating policy, evidence, reimbursement, and trade dynamics into clear strategy, launch plans, execution priorities, and risk‑mitigation pathways for both IV and SubQ formulations.
- Partner closely with alliance and internal stakeholders to ensure Access & Reimbursement Managers (ARMs) and Field Reimbursement teams receive clear direction and real‑time insights that translate strategy into measurable execution improvement
- Regular Travel Required
Who You Are
You are a highly strategic, analytically rigorous senior leader with demonstrated success building and communicating market access strategies for complex specialty biologics. You inspire confidence with executives and alliance partners, can simplify complexity for Investor Relations and Board audiences, and thrive in high‑visibility, high‑stakes roles. You excel at influencing across organizations and navigating the nuanced dynamics of alliance partnerships.
Required Skills
- 15+ years of U.S. Market Access experience with launch leadership in specialty biologics; Alzheimer’s/neuroscience strongly preferred.
- Bachelor’s degree required; advanced degree (MBA, MPH, MS) preferred.
- Experience serving as a advisor to senior leadership, including contributions to Investor Relations, earnings preparation, or Board‑level communications.
- Demonstrated success leading or influencing in alliances/co‑promotions, ideally in situations with high strategic complexity.
- Deep expertise in Medicare (Part B & D), coding/certification pathways, reimbursement mechanics, site‑of‑care economics, and patient support/HUB models.
- Proven ability to define KPIs, derive insights, and lead high‑stakes business reviews.
- Executive presence and exceptional communication skills, including the ability to elevate technical or detailed market access info into crisp narratives for ELT and Board audiences.
- Track record of leading cross‑functional teams and driving impact across large, complex organizations.
Job Level: Management
Additional Information:
The base compensation range for this role is: $238,000.00-$327,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs
About Biogen

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
Employees
Cambridge
Headquarters
Reviews
4.1
47 reviews
Work Life Balance
3.6
Compensation
4.7
Culture
4.1
Career
4.4
Management
3.8
84%
Recommend to a Friend
Pros
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
Cons
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
Salary Ranges
541 data points
Mid/L4
Senior/L5
Mid/L4 · SR Analyst, R&D Business Ops
1 reports
$131,388
total / year
Base
$114,250
Stock
-
Bonus
-
$131,388
$131,388
Interview Experience
47 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
36%
Experience
Positive 65%
Neutral 25%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
FDA grants breakthrough therapy designation to Biogen’s litifilimab - Investing.com
Source: Investing.com
News
·
5w ago
Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen
Source: Biogen
News
·
5w ago
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review - Biogen
Source: Biogen
News
·
5w ago
Biogen’s Alisha Alaimo On The Company’s Next Big Commercial Build - Citeline News & Insights
Source: Citeline News & Insights
News
·
6w ago




